德国住院脑转移病例的流行病学与姑息治疗
该研究基于德国2022年71,787例成人脑转移及软脑膜恶性肿瘤住院病例的横断面分析,评估住院管理、姑息治疗使用与死亡结局。结果显示61.6%为恶性肺肿瘤,14.8%接受专科住院姑息治疗,住院死亡率为13.1%,出院回家占72.7%。
要点
- 71,787例成人脑转移及软脑膜恶性肿瘤住院病例中,53.4%年龄≥65岁,61.6%为恶性肺肿瘤。
- 专科住院姑息治疗覆盖14.8%(10,636例),85.2%未接受该治疗。
- 住院死亡率为13.1%(9413例),其中42.2%的死亡病例接受了专科住院姑息治疗。
核心结论
- 尽管治疗进步,脑转移患者死亡率仍高,作者强调需要整合姑息治疗和综合培训以改善患者结局。
- 作者认为该研究为德国医院脑转移治疗建立了基准,揭示大量患者未接受专科住院姑息治疗,可为神经肿瘤学未来医疗策略提供参考。
研究设计与样本
- 研究为横断面分析,纳入德国医院2022年71,787例成人脑转移及软脑膜恶性肿瘤住院病例。
- 数据来源于医院依据《医院 remuneración 法》第21条提交的资料,聚焦人口学数据、原发肿瘤类型、治疗方法、姑息治疗参与及出院结局。
主要发现
- 71,787例中53.4%为65岁及以上患者。
- 恶性肺肿瘤占61.6%,乳腺癌占12%,恶性黑色素瘤和弥漫性大B细胞淋巴瘤各占6.4%。
- 专科住院姑息治疗覆盖14.8%(10,636例),85.2%未接受该治疗。
- 住院死亡率为13.1%(9413例),其中42.2%的死亡病例接受了专科住院姑息治疗。
- 出院结局包括回家72.7%、转至其他医院7.1%、康复机构0.4%、护理机构2%、临终关怀机构2.4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cerebral metastases (CM) are the most common intracranial neoplasms, significantly impacting patient quality-of-life. Despite advancements in diagnostics and therapeutics, the burden remains high. This study evaluates inpatient management, palliative care use, and mortality outcomes for CM patients in German hospitals in 2022. METHODS: A cross-sectional analysis was conducted on 71,787 inpatient cases involving adult CM and leptomeningeal malignancies patients in German hospitals in 2022. Data submitted by hospitals according to §21 of the Hospital Remuneration Act were analyzed, focusing on demographic data, primary tumor types, treatment methods, participation in palliative care, and discharge outcomes. RESULTS: Among the 71,787 cases, 53.4% were patients aged 65 years or older. Malignant lung tumors were present in 61.6% of cases, followed by breast malignancies (12%) and malignant melanoma and diffuse diffuse large B-cell lymphoma (each 6.4%). Specialized inpatient palliative care (SIPC) was provided in 14.8% (10,636 cases), with 85.2% not receiving such care. Hospital mortality was 13.1% (9413 cases), with 42.2% of these involving patients who received SIPC. Discharge outcomes included discharge home (72.7%), transfers to other hospitals (7.1%), rehabilitation facilities (0.4%), nursing facilities (2%), and hospices (2.4%). CONCLUSION: Despite treatment advances, high mortality rates for CM patients persist, underscoring the need for palliative care integration and comprehensive training to enhance patient outcomes. Health care planning is a growing topic, our study establishes a benchmark for CM care in German hospitals, revealing a significant number of patients not receiving SIPC. This research can inform future healthcare strategies in neuro-oncology.
引用
- Fink L, von Saß C, Golla H, et al. Epidemiology and palliative care of in-patient cerebral metastases cases in Germany. J Neurooncol. 2025. PMID: 40214907. doi:10.1007/s11060-024-04928-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。